Bhv-7000

4 trials 3 recruiting

Filter these 4 trials by condition, phase, country and more.

Open in Search →

4 Registered trials

3 Recruiting

1 Completed trials

1 Sponsors

18 Countries

Phase II/III

Phase II

Phase II/III: 2 Phase II: 2

Sponsors using this IMP

Biohaven Therapeutics Ltd. 4

All trials

4 total

A study to determine if BHV-7000 is safe in adults with refractory focal onset epilepsy Recruiting

2023-508813-18-00 Phase II 18 countries Biohaven Therapeutics Ltd.
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508539-30-00 Phase II 9 countries Biohaven Therapeutics Ltd.
A Study to Determine if BHV-7000 is Effective and Safe in Adults With Refractory Focal Onset Epilepsy Recruiting

2023-508811-21-00 Phase II/III 11 countries Biohaven Therapeutics Ltd.
Efficacy, Safety and Tolerability of BHV-7000 in Subjects with Idiopathic Generalized Epilepsy with Generalized Tonic-clonic Seizures – SHIN… Ended

2023-508812-45-00 Phase II/III 11 countries Biohaven Therapeutics Ltd.

Showing 1–4 of 4 trials

← All drugs A–Z